Go Pro

Alvotech (ALVOW) Competitors

Alvotech logo
$0.30 +0.08 (+35.85%)
As of 11:21 AM Eastern

ALVOW vs. APLMW, ARAV, BIAFW, BIVIW, and CDIOW

Should you buy Alvotech stock or one of its competitors? Alvotech's main competitors and comparable companies include Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Alvotech compare to Apollomics?

Apollomics (NASDAQ:APLMW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
Alvotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
Alvotech$491.95MN/AN/AN/AN/A

In the previous week, Alvotech had 4 more articles in the media than Apollomics. MarketBeat recorded 4 mentions for Alvotech and 0 mentions for Apollomics. Alvotech's average media sentiment score of 0.20 beat Apollomics' score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.

Company Overall Sentiment
Apollomics Neutral
Alvotech Neutral

Summary

Alvotech beats Apollomics on 3 of the 3 factors compared between the two stocks.

How does Alvotech compare to Aravive?

Aravive (NASDAQ:ARAV) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, media sentiment, profitability, institutional ownership and dividends.

In the previous week, Alvotech had 4 more articles in the media than Aravive. MarketBeat recorded 4 mentions for Alvotech and 0 mentions for Aravive. Alvotech's average media sentiment score of 0.20 beat Aravive's score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.

Company Overall Sentiment
Aravive Neutral
Alvotech Neutral

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Alvotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Alvotech$491.95MN/AN/AN/AN/A

Summary

Alvotech beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Alvotech compare to bioAffinity Technologies?

Alvotech (NASDAQ:ALVOW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends.

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
bioAffinity Technologies N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.95MN/AN/AN/AN/A
bioAffinity Technologies$5.85MN/AN/AN/AN/A

In the previous week, Alvotech had 3 more articles in the media than bioAffinity Technologies. MarketBeat recorded 4 mentions for Alvotech and 1 mentions for bioAffinity Technologies. Alvotech's average media sentiment score of 0.20 beat bioAffinity Technologies' score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alvotech
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
bioAffinity Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Alvotech beats bioAffinity Technologies on 3 of the 3 factors compared between the two stocks.

How does Alvotech compare to BioVie?

BioVie (NASDAQ:BIVIW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

In the previous week, Alvotech had 4 more articles in the media than BioVie. MarketBeat recorded 4 mentions for Alvotech and 0 mentions for BioVie. Alvotech's average media sentiment score of 0.20 beat BioVie's score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.

Company Overall Sentiment
BioVie Neutral
Alvotech Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Alvotech$491.95MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Alvotech N/A N/A N/A

Summary

Alvotech beats BioVie on 3 of the 3 factors compared between the two stocks.

How does Alvotech compare to Cardio Diagnostics?

Alvotech (NASDAQ:ALVOW) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, valuation, earnings, risk and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.95MN/AN/AN/AN/A
Cardio Diagnostics$14.45KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

In the previous week, Alvotech had 4 more articles in the media than Cardio Diagnostics. MarketBeat recorded 4 mentions for Alvotech and 0 mentions for Cardio Diagnostics. Alvotech's average media sentiment score of 0.20 beat Cardio Diagnostics' score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company Overall Sentiment
Alvotech Neutral
Cardio Diagnostics Neutral

Summary

Alvotech beats Cardio Diagnostics on 3 of the 3 factors compared between the two stocks.

Get Alvotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALVOW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALVOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALVOW vs. The Competition

MetricAlvotechBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$3.99B$7.29B$12.71B
Dividend YieldN/A3.64%2.54%10.79%
P/E RatioN/A11.78271.3924.10
Price / SalesN/A1,299.82604.5877.05
Price / CashN/A44.9429.0336.90
Price / BookN/A17.2711.186.40
Net IncomeN/A-$22.72M$3.46B$348.28M
7 Day Performance37.47%2.91%1.98%0.92%
1 Month Performance99.33%9.75%7.32%5.10%
1 Year Performance-74.64%54.82%24.76%16.16%

Alvotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALVOW
Alvotech
N/A$0.30
+35.8%
N/A-81.3%$0.00$491.95MN/A4
APLMW
Apollomics
N/A$0.02
-0.6%
N/A-47.4%$0.00$8.50MN/A59
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
BIAFW
bioAffinity Technologies
N/A$0.07
flat
N/A+67.6%$0.00$5.85MN/A10
BIVIW
BioVie
N/A$0.29
+9.4%
N/AN/A$0.00N/AN/AN/A

Related Companies and Tools


This page (NASDAQ:ALVOW) was last updated on 8/24/2026 by MarketBeat.com Staff.
From Our Partners